Evogene
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $312 | $884 | $2,444 | $1,611 |
Gross Profit | -126 | 458 | 251 | 263 |
EBITDA | -1,978 | -2,546 | -1,944 | 752 |
EBIT | -2,259 | -2,836 | -2,523 | 159 |
Net Income | 3,874 | -4,462 | -2,587 | 427 |
Net Change In Cash | 312 | 884 | 2,444 | 1,611 |
Free Cash Flow | -3,801 | -2,303 | -5,304 | -5,529 |
Cash | 5,626 | 8,329 | 7,495 | 15,301 |
Basic Shares | 8,716 | 7,225 | 6,798 | 6,795 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $8,511 | $5,640 | $1,675 | $930 |
Gross Profit | 3,388 | 1,399 | -1,774 | -2,071 |
EBITDA | -15,378 | -23,204 | -26,933 | -27,795 |
EBIT | -17,882 | -25,816 | -29,513 | -30,029 |
Net Income | -16,485 | -23,879 | -26,638 | -27,793 |
Net Change In Cash | 8,511 | 5,640 | 1,675 | 930 |
Free Cash Flow | -20,326 | -22,362 | -24,849 | -25,563 |
Cash | 15,301 | 20,772 | 28,980 | 32,325 |
Basic Shares | 5,697 | 4,568 | 4,121 | 41,013 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.31 |
2025-06-30 | -$0.62 |
2025-03-31 | -$0.38 |
